Disclosure of HIV Status and Adherence to Daily Drug Regimens Among HIV-infected Children in Uganda


Pediatric adherence to daily drug regimens has not been widely assessed in Africa where majority of HIV infected children live. Using in-depth interviews of 42 HIV-infected children taking ART and/or cotrimoxazole prophylaxis, and 42 primary caregivers, at a comprehensive HIV/AIDS clinic in Uganda, we evaluated their adherence experiences for purposes of program improvement. Daily drug regimens provided by the pediatric clinic included cotrimoxazole prophylaxis as well as ART and cotrimoxazole combined. Complete disclosure of HIV status by caregivers to children and strong parental relationships were related to good adherence. Structural factors including poverty and stigma were barriers to adherence even for children who had had complete disclosure and a supportive relationship with a parent. To ensure adherence to life-extending medications, our findings underscore the need for providers to support caregivers to disclose, provide on-going support and maintain open communication with HIV-infected children taking cotrimoxazole prophylaxis and ART.

DOI: 10.1007/s10461-006-9141-3

3 Figures and Tables

Citations per Year

288 Citations

Semantic Scholar estimates that this publication has 288 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{BikaakoKajura2006DisclosureOH, title={Disclosure of HIV Status and Adherence to Daily Drug Regimens Among HIV-infected Children in Uganda}, author={Winnie Bikaako-Kajura and Emmanuel B K Luyirika and David W Purcell and Julia D Downing and Frank Kaharuza and Jonathan Mermin and Samuel S. Malamba and Rebecca E Bunnell}, journal={AIDS and Behavior}, year={2006}, volume={10}, pages={85-93} }